SynthesisScientific reports2023

SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysis.

Thomas A Mavrakanas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.